Outsized Ventures

Outsized Ventures is a venture capital firm that partners with founders pushing the boundaries of science and technology to solve the world’s greatest challenges. They focus on people—innovators, outliers, creators, pioneers, and trailblazers—prioritizing individuals over technology, science, and markets. Their investment process is quick and transparent, offering capital on clean and unfussy terms, with a typical timeline from initial meeting to closing taking as little as 48 hours.

The firm invests in early-stage companies, particularly in the Pre-Seed, Seed, and Series A stages, with typical investments ranging from €1.5 million to €3 million. Their portfolio spans various sectors, including Biotech, Healthtech, Life Sciences, Pharma, Food and Beverage, Machine Learning, and AI. They have a global investment focus, with a particular emphasis on the United Kingdom, United States, Canada, Germany, France, Netherlands, Sweden, Denmark, Norway, Finland, Australia, New Zealand, Singapore, Hong Kong, Japan, South Korea, China, India, South Africa, and Brazil.

Outsized Ventures was founded by Max Ward and Rod Mallo, who bring extensive experience from scientific, engineering, and entrepreneurial backgrounds. The firm is authorized and regulated by the Financial Conduct Authority in the United Kingdom. They have co-invested with various partners, including Knife Capital, and have a track record of supporting companies like Simplestudy, Silian Capital, Biorce, Mixrift, Portal Biotech, Feed Me Seymour Health, Hurdle Bio, Julienne Bruno, Inferex AI, and Emitwise. Their investment philosophy centers on enabling companies to achieve their maximum potential, offering 24/7 availability, sound advice, patience, and backing to the hilt, without seeking to patronize with “value add” services or delusions of grandeur about the importance of a VC in the company building process.